BioSpace News Archive

Press Releases

Entrada Therapeutics Receives Authorization in the European Union to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in Patients Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping

May 28, 2025
·
7 min read
Press Releases

Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference

May 28, 2025
·
2 min read
Press Releases

BioStem Announces Notice of Allowance for Three New U.S. Patent Applications

May 28, 2025
·
5 min read
Press Releases

Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee

May 28, 2025
·
9 min read
Press Releases

AKTIS ONCOLOGY INITIATES PHASE 1B CLINICAL TRIAL OF ITS NECTIN-4-TARGETING RADIOPHARMACEUTICAL PRODUCT CANDIDATE, AKY-1189, ACROSS MULTIPLE TUMOR TYPES

May 28, 2025
·
4 min read
Press Releases

Pimicotinib Demonstrates Best-in-Class Potential with Significant Efficacy and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumor

May 28, 2025
·
7 min read
Press Releases

Pharming Group to participate in June 2025 investor conferences

May 28, 2025
·
1 min read
Press Releases

New Clinical and Scientific Data on TWYMEEG® to be Presented at the 68th Annual Meeting of the Japan Diabetes Society

May 28, 2025
·
7 min read
Press Releases

NANOBIOTIX to Participate in the Jefferies Global Healthcare Investor Conference 2025

May 28, 2025
·
1 min read
Press Releases

Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma

May 28, 2025
·
4 min read